Nanalysis Scientific Corp.
NSCI.V
TSX
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 6.85M | 7.67M | 7.66M | 6.74M | 6.92M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 6.85M | 7.67M | 7.66M | 6.74M | 6.92M |
| Cost of Revenue | 5.06M | 5.95M | 5.58M | 5.27M | 5.24M |
| Gross Profit | 1.79M | 1.72M | 2.08M | 1.47M | 1.68M |
| SG&A Expenses | 1.28M | 1.58M | 1.44M | 1.66M | 2.20M |
| Depreciation & Amortization | 587.20K | 607.60K | 367.30K | 602.60K | 713.40K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 7.05M | 8.30M | 7.43M | 7.59M | 8.25M |
| Operating Income | -205.60K | -629.20K | 223.80K | -850.90K | -1.33M |
| Income Before Tax | -485.10K | -893.10K | -534.40K | -1.08M | -1.56M |
| Income Tax Expenses | -16.20K | 28.00K | -11.50K | 11.60K | -24.60K |
| Earnings from Continuing Operations | -468.90K | -921.20K | -522.90K | -1.09M | -1.53M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -468.90K | -921.20K | -522.90K | -1.09M | -1.53M |
| EBIT | -205.60K | -629.20K | 223.80K | -850.90K | -1.33M |
| EBITDA | 421.10K | -522.10K | 332.80K | -753.60K | -571.00K |
| EPS Basic | 0.00 | -0.01 | 0.00 | -0.01 | -0.01 |
| Normalized Basic EPS | 0.00 | 0.00 | 0.00 | -0.01 | -0.01 |
| EPS Diluted | 0.00 | -0.01 | -0.01 | -0.01 | -0.01 |
| Normalized Diluted EPS | 0.00 | 0.00 | 0.00 | -0.01 | -0.01 |
| Average Basic Shares Outstanding | 138.52M | 136.88M | 117.22M | 114.82M | 113.54M |
| Average Diluted Shares Outstanding | 138.52M | 136.88M | 117.22M | 114.82M | 113.54M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |